Trupanion (NASDAQ:TRUP) Trading Down 5.5% - What's Next?

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) shares traded down 5.5% on Monday . The stock traded as low as $51.58 and last traded at $51.58. 271,596 shares were traded during mid-day trading, a decline of 60% from the average session volume of 679,104 shares. The stock had previously closed at $54.56.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Bank of America upped their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a report on Friday, September 20th. Piper Sandler increased their price target on shares of Trupanion from $45.00 to $57.00 and gave the company a "neutral" rating in a research report on Thursday. Evercore ISI raised Trupanion to a "strong-buy" rating in a research note on Friday, August 9th. Stifel Nicolaus increased their target price on Trupanion from $30.00 to $40.00 and gave the stock a "hold" rating in a research note on Monday, September 23rd. Finally, Northland Securities raised their price target on shares of Trupanion from $45.00 to $50.00 and gave the stock a "market perform" rating in a research note on Thursday. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $44.67.

Trupanion Trading Down 8.3 %

The company has a market cap of $2.11 billion, a price-to-earnings ratio of -156.41 and a beta of 1.69. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.63 and a current ratio of 1.66. The firm has a fifty day moving average price of $47.11 and a 200 day moving average price of $36.63.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. The business had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. Trupanion's revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.10) EPS. As a group, equities analysts predict that Trupanion, Inc. will post -0.34 EPS for the current fiscal year.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the business's stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares of the company's stock, valued at $4,647,256.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CFO Fawwad Qureshi sold 624 shares of the company's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Margaret Tooth sold 7,500 shares of the company's stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company's stock, valued at approximately $4,647,256.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,764 shares of company stock valued at $405,238 in the last quarter. Company insiders own 5.50% of the company's stock.

Hedge Funds Weigh In On Trupanion

Several institutional investors and hedge funds have recently added to or reduced their stakes in TRUP. GAMMA Investing LLC boosted its stake in shares of Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider's stock valued at $61,000 after purchasing an additional 596 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Trupanion in the second quarter valued at $162,000. Oppenheimer Asset Management Inc. bought a new position in shares of Trupanion in the second quarter valued at $235,000. Handelsbanken Fonder AB bought a new position in shares of Trupanion in the third quarter valued at $248,000. Finally, Bayesian Capital Management LP purchased a new stake in shares of Trupanion in the first quarter valued at about $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.